RNS & Investor News

2021

Holding(s) in Company

28 July 2016

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii OptiBiotix Health Plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii Seneca Partners Limited
4. Full name of shareholder(s) (if different from 3.):iv WCS Nominees Limited
Share Nominees Limited
5. Date of the transaction and date on which the threshold is crossed or reached: v 27 July 2016
6. Date on which issuer notified:
7. Threshold(s) that is/are crossed or reached: vi, vii 5%

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares

if possible using the ISIN CODE
Situation previous to the triggering transaction Resulting situation after the triggering transaction
Number of Shares Number of Voting Rights Number of shares Number of voting rights % of voting rights x
Direct Direct xi Indirectxii Direct Indirect
Ordinary shares of £0.02

GB00BP0RTP38
3,908,949 3,908,949 3,858,949 3,858,949 4.95%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration date xiii Exercise/Conversion Period xiv Number of voting rights that may be acquired if the instrument is exercised/ converted. % of voting rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument Exercise price Expiration date xvii Exercise/Conversion period xviii Number of voting rights instrument refers to % of voting rights xix, xx
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
3,858,949 4.95%

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name: Anthony Lappin
15. Contact telephone number: 01942 271 746

 

2020

Holding(s) in Company

28 July 2016

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii OptiBiotix Health Plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii Seneca Partners Limited
4. Full name of shareholder(s) (if different from 3.):iv WCS Nominees Limited
Share Nominees Limited
5. Date of the transaction and date on which the threshold is crossed or reached: v 27 July 2016
6. Date on which issuer notified:
7. Threshold(s) that is/are crossed or reached: vi, vii 5%

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares

if possible using the ISIN CODE
Situation previous to the triggering transaction Resulting situation after the triggering transaction
Number of Shares Number of Voting Rights Number of shares Number of voting rights % of voting rights x
Direct Direct xi Indirectxii Direct Indirect
Ordinary shares of £0.02

GB00BP0RTP38
3,908,949 3,908,949 3,858,949 3,858,949 4.95%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration date xiii Exercise/Conversion Period xiv Number of voting rights that may be acquired if the instrument is exercised/ converted. % of voting rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument Exercise price Expiration date xvii Exercise/Conversion period xviii Number of voting rights instrument refers to % of voting rights xix, xx
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
3,858,949 4.95%

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name: Anthony Lappin
15. Contact telephone number: 01942 271 746

 

2019

Holding(s) in Company

28 July 2016

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii OptiBiotix Health Plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii Seneca Partners Limited
4. Full name of shareholder(s) (if different from 3.):iv WCS Nominees Limited
Share Nominees Limited
5. Date of the transaction and date on which the threshold is crossed or reached: v 27 July 2016
6. Date on which issuer notified:
7. Threshold(s) that is/are crossed or reached: vi, vii 5%

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares

if possible using the ISIN CODE
Situation previous to the triggering transaction Resulting situation after the triggering transaction
Number of Shares Number of Voting Rights Number of shares Number of voting rights % of voting rights x
Direct Direct xi Indirectxii Direct Indirect
Ordinary shares of £0.02

GB00BP0RTP38
3,908,949 3,908,949 3,858,949 3,858,949 4.95%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration date xiii Exercise/Conversion Period xiv Number of voting rights that may be acquired if the instrument is exercised/ converted. % of voting rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument Exercise price Expiration date xvii Exercise/Conversion period xviii Number of voting rights instrument refers to % of voting rights xix, xx
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
3,858,949 4.95%

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name: Anthony Lappin
15. Contact telephone number: 01942 271 746

 

2018

Holding(s) in Company

28 July 2016

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii OptiBiotix Health Plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii Seneca Partners Limited
4. Full name of shareholder(s) (if different from 3.):iv WCS Nominees Limited
Share Nominees Limited
5. Date of the transaction and date on which the threshold is crossed or reached: v 27 July 2016
6. Date on which issuer notified:
7. Threshold(s) that is/are crossed or reached: vi, vii 5%

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares

if possible using the ISIN CODE
Situation previous to the triggering transaction Resulting situation after the triggering transaction
Number of Shares Number of Voting Rights Number of shares Number of voting rights % of voting rights x
Direct Direct xi Indirectxii Direct Indirect
Ordinary shares of £0.02

GB00BP0RTP38
3,908,949 3,908,949 3,858,949 3,858,949 4.95%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration date xiii Exercise/Conversion Period xiv Number of voting rights that may be acquired if the instrument is exercised/ converted. % of voting rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument Exercise price Expiration date xvii Exercise/Conversion period xviii Number of voting rights instrument refers to % of voting rights xix, xx
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
3,858,949 4.95%

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name: Anthony Lappin
15. Contact telephone number: 01942 271 746

 

2017

Holding(s) in Company

28 July 2016

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii OptiBiotix Health Plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii Seneca Partners Limited
4. Full name of shareholder(s) (if different from 3.):iv WCS Nominees Limited
Share Nominees Limited
5. Date of the transaction and date on which the threshold is crossed or reached: v 27 July 2016
6. Date on which issuer notified:
7. Threshold(s) that is/are crossed or reached: vi, vii 5%

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares

if possible using the ISIN CODE
Situation previous to the triggering transaction Resulting situation after the triggering transaction
Number of Shares Number of Voting Rights Number of shares Number of voting rights % of voting rights x
Direct Direct xi Indirectxii Direct Indirect
Ordinary shares of £0.02

GB00BP0RTP38
3,908,949 3,908,949 3,858,949 3,858,949 4.95%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration date xiii Exercise/Conversion Period xiv Number of voting rights that may be acquired if the instrument is exercised/ converted. % of voting rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument Exercise price Expiration date xvii Exercise/Conversion period xviii Number of voting rights instrument refers to % of voting rights xix, xx
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
3,858,949 4.95%

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name: Anthony Lappin
15. Contact telephone number: 01942 271 746

 

2016

Holding(s) in Company

28 July 2016

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii OptiBiotix Health Plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii Seneca Partners Limited
4. Full name of shareholder(s) (if different from 3.):iv WCS Nominees Limited
Share Nominees Limited
5. Date of the transaction and date on which the threshold is crossed or reached: v 27 July 2016
6. Date on which issuer notified:
7. Threshold(s) that is/are crossed or reached: vi, vii 5%

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares

if possible using the ISIN CODE
Situation previous to the triggering transaction Resulting situation after the triggering transaction
Number of Shares Number of Voting Rights Number of shares Number of voting rights % of voting rights x
Direct Direct xi Indirectxii Direct Indirect
Ordinary shares of £0.02

GB00BP0RTP38
3,908,949 3,908,949 3,858,949 3,858,949 4.95%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration date xiii Exercise/Conversion Period xiv Number of voting rights that may be acquired if the instrument is exercised/ converted. % of voting rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument Exercise price Expiration date xvii Exercise/Conversion period xviii Number of voting rights instrument refers to % of voting rights xix, xx
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
3,858,949 4.95%

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name: Anthony Lappin
15. Contact telephone number: 01942 271 746

 

2015

Holding(s) in Company

28 July 2016

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii OptiBiotix Health Plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii Seneca Partners Limited
4. Full name of shareholder(s) (if different from 3.):iv WCS Nominees Limited
Share Nominees Limited
5. Date of the transaction and date on which the threshold is crossed or reached: v 27 July 2016
6. Date on which issuer notified:
7. Threshold(s) that is/are crossed or reached: vi, vii 5%

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares

if possible using the ISIN CODE
Situation previous to the triggering transaction Resulting situation after the triggering transaction
Number of Shares Number of Voting Rights Number of shares Number of voting rights % of voting rights x
Direct Direct xi Indirectxii Direct Indirect
Ordinary shares of £0.02

GB00BP0RTP38
3,908,949 3,908,949 3,858,949 3,858,949 4.95%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration date xiii Exercise/Conversion Period xiv Number of voting rights that may be acquired if the instrument is exercised/ converted. % of voting rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument Exercise price Expiration date xvii Exercise/Conversion period xviii Number of voting rights instrument refers to % of voting rights xix, xx
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
3,858,949 4.95%

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name: Anthony Lappin
15. Contact telephone number: 01942 271 746

 

2014

Holding(s) in Company

28 July 2016

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii OptiBiotix Health Plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii Seneca Partners Limited
4. Full name of shareholder(s) (if different from 3.):iv WCS Nominees Limited
Share Nominees Limited
5. Date of the transaction and date on which the threshold is crossed or reached: v 27 July 2016
6. Date on which issuer notified:
7. Threshold(s) that is/are crossed or reached: vi, vii 5%

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares

if possible using the ISIN CODE
Situation previous to the triggering transaction Resulting situation after the triggering transaction
Number of Shares Number of Voting Rights Number of shares Number of voting rights % of voting rights x
Direct Direct xi Indirectxii Direct Indirect
Ordinary shares of £0.02

GB00BP0RTP38
3,908,949 3,908,949 3,858,949 3,858,949 4.95%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration date xiii Exercise/Conversion Period xiv Number of voting rights that may be acquired if the instrument is exercised/ converted. % of voting rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument Exercise price Expiration date xvii Exercise/Conversion period xviii Number of voting rights instrument refers to % of voting rights xix, xx
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
3,858,949 4.95%

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name: Anthony Lappin
15. Contact telephone number: 01942 271 746

 

2013

Holding(s) in Company

28 July 2016

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii OptiBiotix Health Plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii Seneca Partners Limited
4. Full name of shareholder(s) (if different from 3.):iv WCS Nominees Limited
Share Nominees Limited
5. Date of the transaction and date on which the threshold is crossed or reached: v 27 July 2016
6. Date on which issuer notified:
7. Threshold(s) that is/are crossed or reached: vi, vii 5%

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares

if possible using the ISIN CODE
Situation previous to the triggering transaction Resulting situation after the triggering transaction
Number of Shares Number of Voting Rights Number of shares Number of voting rights % of voting rights x
Direct Direct xi Indirectxii Direct Indirect
Ordinary shares of £0.02

GB00BP0RTP38
3,908,949 3,908,949 3,858,949 3,858,949 4.95%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration date xiii Exercise/Conversion Period xiv Number of voting rights that may be acquired if the instrument is exercised/ converted. % of voting rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument Exercise price Expiration date xvii Exercise/Conversion period xviii Number of voting rights instrument refers to % of voting rights xix, xx
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
3,858,949 4.95%

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name: Anthony Lappin
15. Contact telephone number: 01942 271 746